Startup Media Story

News Archive

GraphWear presented SweatSmart beta at the NASDAQ

GraphWear presented SweatSmart beta at the NASDAQ GraphWear presented SweatSmart beta at the NASDAQ bell closing ceremony along with the CEO of the 49ers, Jed York and were featured on Times Square. This is the first time in human history that players would be able to extract their health information in real-time without blood pricks and they are excited to […]

Read more

David Seftel featured in San Francisco Chronicle

David Seftel featured in San Francisco Chronicle One of the great aspects of our community, are the wonderful people we work with.  Reading the front page of the Chronicle recently, we discovered that Dr. David Seftel is not only a co-founder of Enable Biosciences, but he also has a storied past of resisting Apartheid in South Africa and then becoming the […]

Read more

LogicInk – Is the future of wearable health tech ….TATTOOS?

Is the future of wearable health tech ….TATTOOS? A Talk at Techonomy On November 9th 2016, LogicInk gave their first public talk as a company at a conference called Techonomy in Half Moon Bay, CA. What happens when low-cost biosensors embedded in tattoos can detect blood alcohol, sugar, or biomarkers related to diseases like malaria or zika? How will that […]

Read more

Avant Completes Acquisitions of Amarantus, Theranostics Health

Avant Completes Acquisitions of Amarantus and Theranostics Health Avant Diagnostics announced today that it has completed its previously announced acquisitions of Amarantus Diagnostics and protein analysis services provider Theranostics Health. In January, Scottsdale, Arizona-based Avant inked a deal to merge with Amarantus Diagnostics, a subsidiary of therapeutics developer Amarantus Bioscience. The arrangement joins Amarantus’ research-use-only assays for multiple sclerosis and […]

Read more

ViewPoint Therapeutics Raises $4 Million in Series A Financing

ViewPoint Therapeutics Raises $4 Million in Series A Financing ViewPoint Therapeutics, Inc., a privately-held biotechnology company pioneering the development of crystallin stabilizers to prevent and treat cataracts and presbyopia, today announced the closing of a $4 million Series A financing. The transaction was co-led by Mission Bay Capital and Lagunita BioSciences LLC. Also included in the syndicate was healthcare-dedicated investor, […]

Read more

Miroculus Acquires Microfluidics Firm Kapplex

MicroRNA Diagnostics Developer Miroculus Acquires Microfluidics Firm Kapplex Miroculus, a San Francisco startup developing microRNA-based diagnostic tests, said Monday that it has acquired Toronto-based microfluidics firm Kapplex for an undisclosed amount. Miroculus emerged from stealth mode earlier this year at Cambridge Healthtech Institute’s Molecular Medicine Tri-Conference. It aims to tap into the growing evidence that miRNAs can serve as useful […]

Read more

Dow AgroSciences and TeselaGen to collaborate

A new collaboration between Dow AgroSciences and TeselaGen Biotechnology Inc. is designed to produce a biological design automation platform that can speed up discovery work for new agricultural products. “TeselaGen has created a powerful suite of tools for DNA design,” said Daniel R. Kittle, Ph.D., vice president, research and development, Dow AgroSciences. “These tools have the potential to accelerate our […]

Read more

Perlstein Lab continues their rare disease drug discovery

Perlstein Lab, or PLab as it is also known, continues to hone its automated drug discovery platform and presents its latest iteration Wednesday March 23rd at Y Combinator Demo Day. The platform they created helps the bio startup focus on finding cures for rare diseases rather than common ones. This novel approach is different from most Big Pharma labs and […]

Read more

Startup Miroculus Shares Vision for Rapid, Inexpensive miRNA Diagnostics at Tri-Con

Molecular diagnostics startup Miroculus is going all in on microRNAs as the ideal blood-based biomarker for diagnosing and monitoring a number of diseases and even tracking an individual’s general physiological well-being at the point of care and in resource-poor areas of the world, the company’s chief technology officer said this week. In a keynote presentation at Cambridge Healthtech Institute’s Molecular […]

Read more

IBM Watson adds Tiatros patient-centered social network to system

San Francisco start-up Tiatros, a doctor-driven, patient-centered social network, has joined the IBM Watson Ecosystem, the companies announced March 2 at HIMSS16. Tiatros was designed to allow physicians, with the consent of patients, to create a social network around the patient, including all doctors involved in their treatment and their family members. The first user of the platform was the […]

Read more
Page 1 of 512345

Address

953 Indiana St.
San Francisco, CA 94107
Tel: (415)-347-8287

Sign-Up for our Newsletter